Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice-Reference-Cited by-同舟云学术

Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice

Published:2023-11-14 Issue: Volume: Page:
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Huang Hui,Xue Jie,Xie Mei-Lin^ORCID,Xie Tao^ORCID

Funder

Research Fund of Nanjing Medical University

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-023-02173-8.pdf

Reference35 articles.

1. Wang L, Li J, Di LJ (2022) Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. Med Res Rev 42:946–982

2. Emma MR, Augello G, Cusimano A, Azzolina A, Montalto G, McCubrey JA, Cervello M (2020) GSK‑3 in liver diseases: friend or foe? Biochim Biophys Acta Mol Cell Res 1867:118743

3. Zhang N, Liu XJ, Liu L, Deng ZS, Zeng QX, Pang WQ, Liu Y, Song DQ, Deng HB (2018) Glycogen synthase kinase-3beta inhibition promotes lysosome-dependent degradation of c‑FLIPL in hepatocellular carcinoma. Cell Death Dis 9:230

4. Fang GX, Zhang PL, Liu JF, Zhang X, Zhu XJ, Li R, Wang HY (2019) Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling. Cancer Lett 463:11–26

5. Tang L, Wei F, Wu YF, He Y, Shi L, Xiong F, Gong ZJ, Guo C, Li XY, Deng H, Cao K, Zhou M, Xiang B, Li XL, Li Y, Li GY, Xiong W, Zeng ZY (2018) Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res 37:87

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway;BMC Cancer;2024-09-02